We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
+4.4%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.06B
AUM Growth
+$28.4M
(+0.94%)
Cap. Flow
-$1.45B
Cap. Flow
% of AUM
-47.27%
Top 10 Holdings %
Top 10 Hldgs %
37.02%
Holding
99
New
15
Increased
19
Reduced
16
Closed
14
Top Buys
| 1 |
Keros Therapeutics
KROS
|
+$50.1M |
| 2 |
Boston Scientific
BSX
|
+$37.5M |
| 3 |
Viridian Therapeutics
VRDN
|
+$30.9M |
| 4 |
Maravai LifeSciences
MRVI
|
+$24.4M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$21.7M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$90.4M |
| 2 |
Glaukos
GKOS
|
+$43.8M |
| 3 |
Amgen
AMGN
|
+$39M |
| 4 |
Intuitive Surgical
ISRG
|
+$30M |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
+$29.7M |
Sector Composition
| 1 | Healthcare | 54.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$17.3B
| $88M | 2.88% |
933,362
+166,562
| +22% | +$16.3M |
|
2
Vaxcyte
PCVX
$8.19B
| $86M | 2.81% |
1,722,353
+402,375
| +30% | +$19.1M |
|
3
Align Technology
ALGN
$13B
| $79.2M | 2.59% |
224,030
+16,900
| +8% | +$5.38M |
|
|
4
Glaukos
GKOS
$9.21B
| $74.4M | 2.43% |
1,044,392
-762,259
| -42% | -$43.8M |
|
5
Xenon Pharmaceuticals
XENE
$6.55B
| $70.4M | 2.3% |
1,828,353
-308,757
| -14% | -$12.3M |
|
6
Natera
NTRA
$39.7B
| $56.1M | 1.83% |
1,152,851
+170,610
| +17% | +$8.7M |
|
|
DCPH
7
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $51.3M | 1.68% |
3,646,419
+405,068
| +12% | +$5.8M |
|
8
iRhythm Holdings
IRTC
$3.72B
| $49.9M | 1.63% |
478,557
+24,388
| +5% | +$2.93M |
|
|
DICE
9
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $47.8M | 1.56% |
1,029,901
+45,101
| +5% | +$1.56M |
|
|
10
Keros Therapeutics
KROS
$218M
| $46M | 1.5% |
+1,143,865
| New | +$50.1M |
|
|
NVRO
11
DELISTED
NEVRO CORP.
NVRO
| $45.2M | 1.48% |
1,776,368
+143,453
| +9% | +$4.14M |
|
|
12
Intuitive Surgical
ISRG
$138B
| $42.3M | 1.38% |
123,820
-99,300
| -45% | -$30M |
|
|
MRUS
13
DELISTED
Merus
MRUS
| $40.6M | 1.33% |
1,543,162
+70,078
| +5% | +$1.53M |
|
|
DAWN
14
DELISTED
Day One Biopharmaceuticals
DAWN
| $40.1M | 1.31% |
3,361,813
+201,918
| +6% | +$2.64M |
|
|
15
Boston Scientific
BSX
$64B
| $38.8M | 1.27% |
+717,050
| New | +$37.5M |
|
16
Legend Biotech
LEGN
$4.46B
| $38.4M | 1.25% |
556,301
-45,500
| -8% | -$2.97M |
|
|
FNA
17
DELISTED
Paragon 28, Inc.
FNA
| $37.9M | 1.24% |
2,136,122
+1,037,400
| +94% | +$18.6M |
|
18
Biogen
BIIB
$29.1B
| $34.7M | 1.14% |
121,942
-98,800
| -45% | -$29.4M |
|
19
OrthoPediatrics
KIDS
$507M
| $33.4M | 1.09% |
761,208
-237,663
| -24% | -$11M |
|
20
Outset Medical
OM
$84M
| $31.9M | 1.04% |
97,358
-19,599
| -17% | -$5.98M |
|
21
Aclaris Therapeutics
ACRS
$782M
| $30.1M | 0.98% |
2,901,194
-367,900
| -11% | -$3.33M |
|
|
AXNX
22
DELISTED
Axonics, Inc. Common Stock
AXNX
| $29M | 0.95% |
573,791
+407,087
| +244% | +$21.7M |
|
|
23
Viridian Therapeutics
VRDN
$2.1B
| $28.7M | 0.94% |
+1,206,300
| New | +$30.9M |
|
24
Krystal Biotech
KRYS
$10.3B
| $28.3M | 0.93% |
241,399
-106,637
| -31% | -$10.9M |
|
25
Immunocore
IMCR
$1.76B
| $28.1M | 0.92% |
468,027
+41,917
| +10% | +$2.39M |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM